APA (7th ed.) Citation

AB, A., Z, L., HH, G., B, F., R, D., V, A., & S, S. (2025). Challenging Traditional ADME Assumptions for Physiologically Based Pharmacokinetic Models for Intravenous Administration of Iron-Carbohydrate Nanomedicines: Potential Utility of Gold Nanoparticle Models as a Roadmap. Clinical pharmacokinetics, 64(10), 1477. https://doi.org/10.1007/s40262-025-01561-w

Chicago Style (17th ed.) Citation

AB, Alston, Lin Z, Gustafson HH, Flühmann B, Digigow R, Ayala-Nunez V, and Schmidt S. "Challenging Traditional ADME Assumptions for Physiologically Based Pharmacokinetic Models for Intravenous Administration of Iron-Carbohydrate Nanomedicines: Potential Utility of Gold Nanoparticle Models as a Roadmap." Clinical Pharmacokinetics 64, no. 10 (2025): 1477. https://doi.org/10.1007/s40262-025-01561-w.

MLA (9th ed.) Citation

AB, Alston, et al. "Challenging Traditional ADME Assumptions for Physiologically Based Pharmacokinetic Models for Intravenous Administration of Iron-Carbohydrate Nanomedicines: Potential Utility of Gold Nanoparticle Models as a Roadmap." Clinical Pharmacokinetics, vol. 64, no. 10, 2025, p. 1477, https://doi.org/10.1007/s40262-025-01561-w.